AIM Global, the trade association for automatic identification technology, will partner with the Georgia Tech Research Institute (GTRI) and MET Laboratories to develop testing protocols for RFID technology in a health care setting, as well as investigating the effects RFID may have on implantable medical devices. The team aims to have testing guidelines ready for presentation to the Food and Drug Administration by December of this year. The project, known as the AIM Global Healthcare Initiative is overseen by AIM Global’s RFID Experts Group (REG), which includes representatives from 40 organizations with experts in RFID technology in the United States, Europe, and Asia.While there have been multiple tests conducted by universities, manufacturers, and other groups regarding specific RF frequencies to ensure that RF emissions do not interfere with medical equipment, there are no formal guidelines regarding the testing of RFID with medical devices. This lack is explained by the fact that RFID is a relatively new technology. The members of this initiative hope to provide RFID vendors and medical device manufacturers with a comprehensive guide for testing the RFID technology that may be introduced into a hospital or other healthcare setting.See the announcement on the AIM Global website.
About the Author
Established in 1970, Interference Technology helps EMI/EMC engineers find solutions to their various testing, design, application and regulatory issues by publishing articles, news and other practical content. We help suppliers in these areas to find the right customers for their components, materials, test equipment and services through a wide range of marketing services, including lead generation, branding, market research and events. The publication is available in various printed and electronic media formats, with readers in over 60 countries. We also publish issues in local languages in China, Japan and Europe.